Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study - Stangier, J; Rathgen, K; Stähle, H (Clin Pharmacokinet, 2010)
et al.